stockrow
Friday 6 November 2026
Export DMTKQ’s income statement to Excel — free account
DermTech, Inc.
DMTKQ Healthcare Diagnostics & Research
DermTech, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $15.3 million, up 5.36% from fiscal 2022.
0.00
0.00
NaN
Follow DMTKQ
Alert me
| Older periods | Jun '23 | Sep '23 | Dec '23 | Mar '24 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 3 | 3 | 4 |
| (89.73%) | (96.49%) | (106.46%) | (121.75%) | ||
| (64.11%) | (66.29%) | (62.28%) | (64.00%) | ||
ROIC |
(3,954.90%) | (1,437.56%) | (4,806.29%) | (5,493.45%) | |
Return on Tangible Assets |
(142.75%) | (159.67%) | (189.31%) | (247.73%) | |
Average Days of Receivables |
100.59 | 91.59 | 61.66 | 58.18 | |
Free Cash Flow per Share |
(2.96) | (2.62) | (2.39) | (2.08) | |
Free Cash Flow |
(94.22) | (88.50) | (77.88) | (72.07) | |
Capital Expenditures |
(2.96) | (3.00) | (0.90) | — | |
| Other line items | |||||
Cash ROIC |
(54.05%) | (62.63%) | (68.87%) | (91.22%) | |
Accounts Receivable Turnover |
2.85 | 2.96 | 4.53 | 5.06 | |
Accounts Payable Turnover |
9.32 | 6.33 | 7.70 | 7.98 | |
Inventory Turnover |
10.66 | 11.51 | 10.88 | 11.92 | |
Average Days of Payables |
57.17 | 41.76 | 36.06 | 48.72 | |
Days of Inventory on Hand |
33.26 | 29.33 | 24.40 | 21.17 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
136.16% | 118.25% | 99.63% | 89.99% | |
Selling, General and Administrative Expense of Revenue |
730.24% | 663.78% | 580.39% | 507.14% | |
Share Based Compensation of Revenue |
160.11% | 143.96% | 121.37% | 105.50% | |
Operating CF/Net income |
0.76 | 0.78 | 0.76 | 0.80 | |
Depreciation/Fixed assets |
0.93 | 1.02 | 1.07 | 1.10 | |
Capex/Depreciation |
(0.52) | (0.52) | (0.17) | 0.00 | |
Revenue per Share |
0.44 | 0.42 | 0.47 | 0.45 | |
Operating CF per Share |
(2.87) | (2.53) | (2.36) | (2.08) | |
Capex per Share |
(0.09) | (0.09) | (0.03) | 0.00 | |
Capex to Sales |
0.21 | 0.21 | 0.06 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026